Highlights
NASDAQ: ONCE       Spark Therap
Last Price Today's Change   Day's Range   Trading Volume
55.02   +0.83 (1.53%)  51.41 - 55.17  568,672

Overview

 
Avg Volume (4 weeks):651,327
4 Weeks Range:48.99 - 60.77
4 Weeks Price Volatility (%):
51.19%
52 Weeks Range:41.06 - 91.75
52 Weeks Price Volatility (%):
27.54%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.

  Be the first to like this.
 


 

5109  2260  622  588 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SPY 274.71+4.31 
 CHK 3.200.00 
 GE 14.49-0.13 
 BAC 32.03+0.34 
 QQQ 168.17+3.37 
 MU 46.53+2.28 
 HPE 18.14+1.73 
 EEM 49.72+0.87 
 XLF 29.12+0.43 
 UVXY 14.82-2.66 
Partners & Brokers